MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.59
-0.01 (-0.08%)
At close: May 28, 2025, 4:00 PM
12.52
-0.07 (-0.56%)
After-hours: May 28, 2025, 5:07 PM EDT
MBX Biosciences Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for MBX Biosciences stock ranges from a low of $30 to a high of $44. The average analyst price target of $37.4 forecasts a 197.06% increase in the stock price over the next year.
Price Target: $37.40 (+197.06%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 10, 2025.
Analyst Ratings
The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +201.83% | Apr 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +249.48% | Apr 10, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +178.00% | Oct 8, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +138.28% | Oct 8, 2024 |
| Stifel | Stifel | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +217.71% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.84
from -5.82
EPS Next Year
-2.70
from -2.84
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.63 | -2.33 | -2.53 |
| Avg | -2.84 | -2.70 | -3.61 |
| Low | -2.97 | -3.12 | -4.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.